Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

AI Analyst Top Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Private Companies

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Editas Medicine Inc (EDIT)

NASDAQ:EDIT

US Market

EDIT

Editas Medicine

RESEARCH TOOLSreports

Editas Medicine (EDIT) Stock News & Sentiment

3,558 Followers

Regulatory Disruptions at FDA Threaten Editas Medicine’s Gene-Editing Timelines and Commercial Prospects

Company Announcements

Regulatory Disruptions at FDA Threaten Editas Medicine’s Gene-Editing Timelines and Commercial Prospects

3d ago

EDIT Upcoming Earnings Report: What to Expect?

Pre-Earnings

EDIT Upcoming Earnings Report: What to Expect?

25d ago

Cautious Hold Rating on Editas Medicine Amid Promising Preclinical Results and Development Uncertainties

Ratings

Cautious Hold Rating on Editas Medicine Amid Promising Preclinical Results and Development Uncertainties

4M ago

Editas Medicine Reports Q3 2025 Progress and Financials

Company Announcements

Editas Medicine Reports Q3 2025 Progress and Financials

4M ago

Editas Medicine Inc. (EDIT) Q3 Earnings Cheat Sheet

Pre-Earnings

Editas Medicine Inc. (EDIT) Q3 Earnings Cheat Sheet

4M ago

Editas Medicine’s Long-Term Study on EDIT-301: A Potential Game-Changer for Hemoglobinopathies

Company Announcements

Editas Medicine’s Long-Term Study on EDIT-301: A Potential Game-Changer for Hemoglobinopathies

5M ago

Editas Medicine Unveils Promising Preclinical Data on EDIT-401

Company Announcements

Editas Medicine Unveils Promising Preclinical Data on EDIT-401

5M ago

More EDIT News >

EDIT News on the Web

2026-03-12

Editas Medicine Inc at Barclays Global Healthcare Conference Transcript

GuruFocus News

Neutral

2026-03-11

Regulatory Disruptions at FDA Threaten Editas Medicine’s Gene-Editing Timelines and Commercial Prospects

TipRanks News

Bearish

2026-03-10

EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y

Zacks

Neutral

2026-03-10

Editas Medicine upgraded to Buy from Hold at JonesResearch

TipRanks News

Bullish

2026-03-10

Editas Medicine Sharpens Focus on EDIT-401 as Cash Runway Extends Into Q3 2027

Market Chameleon

Neutral

2026-03-10

Wells Fargo Sticks to Its Hold Rating for Editas Medicine (EDIT)

TipRanks News

Neutral

2026-03-10

RBC Capital Keeps Their Hold Rating on Editas Medicine (EDIT)

TipRanks News

Neutral

2026-03-10

Clear Street Reaffirms Their Buy Rating on Editas Medicine (EDIT)

TipRanks News

Neutral

News Score - Last 7 Days

Positive

EDIT

Sector Average

Media Buzz

This Week13 articles

Weekly Average4 articles

News Sentiment

This Week75%

Sector Average70%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is EDIT’s Media Buzz Sentiment?

13 articles about EDIT were published this week. In an average week, 4 articles are published.

What is EDIT’s weekly average amount of articles?

In an average week, 4 articles about EDIT are published.

What is EDIT’s News Sentiment?

75% of articles about EDIT were positive this week, compared to its sector average of 70%.

Healthcare Stocks that are Trending in the News

SKYESkye Bioscience

RPIDRapid Micro Biosystems

SGMTSagimet Biosciences, Inc. Class A

KRMDREPRO-MED Systems

GRDNGuardian Pharmacy Services, Inc. Class A

Showing the stocks with the most bullish news sentiment over the past week